Exact Mass: 285.1648

Isococculidine

Isococculidine; Erythrinan, 1,2-didehydro-3,15-dimethoxy-, (3-beta)-

2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C308 - Immunotherapeutic Agent

N-Monodesmethyl-rizatriptan

3-[2-(dimethylamino)ethyl]-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-6-ol

N-Monodesmethyl-rizatriptan is a metabolite of rizatriptan. Rizatriptan (Maxalt) is a 5-HT1 agonist triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT). Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29, 1998. It is a second-generation triptan. Rizatriptan is available only by prescription in Australia, the United States, Canada and New Zealand. (Wikipedia)

(1R,9S)-10-(Cyclopropylmethyl)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-8-one

1-Tert-butyl 4-ethyl 5-oxoazepane-1,4-dicarboxylate

1-Tert-butyl 4-ethyl 5-oxoazepane-1,4-dicarboxylic acid

C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

ISOPROPYL 3-CYCLOPENTYL-1-METHYL-1H-INDOLE-6-CARBOXYLATE

2-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]acetamide

N-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-2-amine

Ketazocine

2-(3-METHYL-1H-PYRAZOL-1-YL)-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

Boc-Pyr-OtBu

Butinazocine

ditert-butyl (2S)-4-oxopyrrolidine-1,2-dicarboxylate

2-Oxa-7-azaspiro[4.5]decane-3,7-dicarboxylic acid7-tert-butyl ester

1-O-tert-butyl 3-O-ethyl 4-oxoazepane-1,3-dicarboxylate

ETHYL 5-(TERT-BUTYL)-2-METHYL-1-PHENYL-1H-PYRROLE-3-CARBOXYLATE

(R)-2-(2-ETHOXYCARBONYL-ACETYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

1-Boc-4-phenylethynyl-piperidine

9-[(2-methylpropan-2-yl)oxycarbonyl]-1-oxa-9-azaspiro[4.5]decane-3-carboxylic acid

8-(Tert-Butoxycarbonyl)-1-Oxa-8-Azaspiro[4.5]Decane-2-Carboxylic Acid

8-[(2-methylpropan-2-yl)oxycarbonyl]-1-oxa-8-azaspiro[4.5]decane-3-carboxylic acid

1-[1-(1-Benzothiophen-2-yl)cyclohexyl]pyrrolidine

1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)pyrrolidine

C18H23NS (285.1551)

N-benzyl-2-(3,4-dimethoxyphenyl)-N-methylethanamine

tert-Butyl spiro[indene-1,4-piperidine]-1-carboxylate

1-TERT-BUTYL 3-METHYL 3-ETHYL-4-OXOPIPERIDINE-1,3-DICARBOXYLATE

(2R)-5-Oxo-1,2-pyrrolidinedicarboxylic acid 1,2-bis(tert-butyl) ester

4-((4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)METHYL)PYRIDINE

citral / methyl anthranilate schiffs base

ETHYL1-(TERT-BUTOXYCARBONYLAMINO)-4-OXOCYCLOHEXANECARBOXYLATE

(S)-BoroPro-(-)-Pinanediol-HCl

C14H25BClNO2 (285.1667)

3-((4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)METHYL)PYRIDINE

2-((4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)METHYL)PYRIDINE

Orm-12741

6-Hydroxyrizatriptan

Prolyl-leucyl-glycine

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

(2S)-2-[[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]-4-methylpentanoic acid

Gly-Pro-Ile

L-Valyl-L-prolyl-L-alanine

L-Prolylglycyl-L-isoleucine

CID 23724935

4-DMA L-abrine

C17H21N2O2- (285.1603)

N-Propionyl-N-(4,6,7-trimethyl-quinazolin-2-yl)-guanidine

[(1S,5R)-8-methyl-8-azoniabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate

C17H21N2O2+ (285.1603)

Pro-Ile-Gly

9-oxo-N-(1-phenylethyl)bicyclo[3.3.1]nonane-3-carboxamide

1-(2-Ethyl-3-benzofuranyl)-3-(1-piperidinyl)-1-propanone

N,N-di(propan-2-yl)-2-[(1-propyl-5-tetrazolyl)thio]acetamide

C12H23N5OS (285.1623)

beta-Saxitoxinol(2+)

C10H19N7O3+2 (285.1549)

(E)-1-hydroxy-2-(non-1-en-1-yl)quinolin-4-one

A hydroxylamine that is N-hydroxyquinolin-4-one in which the hydrogen at position 2 has been replaced by a (1E)-non-1-en-1-yl group. It is the most active agent produced by Pseudomonas aeruginosa that modulates the growth and virulence of Staphylococcus aureus; the corresponding Z isomer is inactive.

Ala-Pro-Val

Gly-Ile-Pro

Gly-Leu-Pro

Ile-Pro-Gly

Leu-Pro-Gly

Pro-Val-Ala

Ile-Gly-Pro

Pro-Gly-Leu

Val-Ala-Pro

4-[Methyl-(phenylmethyl)amino]-1-phenylbutane-1,3-diol

Ala-Val-Pro

Pro-Ala-Val

Gly-Pro-Leu

Pro-Gly-Ile

Pro-Leu-Gly

Val-Pro-Ala

(2s,3s,4r)-3-methyl-2-[(1e,3e)-4-phenylbuta-1,3-dien-1-yl]piperidin-4-yl acetate

1-[(5s)-2,4-dihydroxy-5-isopropyl-5h-pyrrol-3-yl]-5-hydroxy-3-methoxyhexan-1-one

n-[(4s,5r,7s,9s)-7-ethyl-9-hydroxy-8,8-dimethyl-2-oxo-1,6-dioxaspiro[4.5]decan-4-yl]ethanimidic acid

(9bs,11s)-8,11-dimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline

3,6-bis({[(2r)-3,3-dimethyloxiran-2-yl]methyl})-1h-indole

3,3-bis(but-3-en-1-yl)-4-methoxy-4h-quinolin-2-ol

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-3-methylbut-2-enimidic acid

2-(nonan-8-one)-(1h)-4-quinolone

{"Ingredient_id": "HBIN006129","Ingredient_name": "2-(nonan-8-one)-(1h)-4-quinolone","Alias": "NA","Ingredient_formula": "C18H23NO2","Ingredient_Smile": "COC1C2=CC=CC=C2NC(=O)C1(CCC=C)CCC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15682","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3,3-dimethylallyl-4-methoxy-2-quinolone

{"Ingredient_id": "HBIN007181","Ingredient_name": "3,3-dimethylallyl-4-methoxy-2-quinolone","Alias": "NA","Ingredient_formula": "C18H23NO2","Ingredient_Smile": "COC1C2=CC=CC=C2NC(=O)C1(CCC=C)CCC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15154","TCMID_id": "6307","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-dimethylallyl-4-methoxy-2-quinolone